Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4206-4216
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4206
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4206
Parameter | Polyp group | Non-polyp group | χ2 value | P value |
High blood pressure | 94 (66.67) | 49 (53.26) | 4.421 | 0.054 |
CAD | 36 (25.53) | 17 (18.48) | 1.576 | 0.209 |
Fatty liver | 74 (52.48) | 45 (48.91) | 0.324 | 0.569 |
Atherosclerosis | 110 (78.01) | 65 (70.65) | 2.833 | 0.002a |
Aspirin use | 36 (25.53) | 18 (19.57) | 1.113 | 0.291 |
Statin use | 88 (62.41) | 59 (64.13) | 0.071 | 0.790 |
Smoking | 59 (41.84) | 29 (31.52) | 2.524 | 0.112 |
Drinking | 49 (34.75) | 29 (31.52) | 0.261 | 0.610 |
- Citation: Wu XQ, Deng LH, Xue Q, Li X, Li MH, Wang JT. Metformin administration in prevention of colorectal polyps in type 2 diabetes mellitus patients. World J Clin Cases 2024; 12(20): 4206-4216
- URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4206.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4206